600216 Stock Overview
Manufactures and sells life nutrition and pharmaceutical products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Zhejiang Medicine Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.86 |
| 52 Week High | CN¥19.40 |
| 52 Week Low | CN¥7.97 |
| Beta | 0.096 |
| 11 Month Change | -5.09% |
| 3 Month Change | 8.70% |
| 1 Year Change | 40.48% |
| 33 Year Change | -5.93% |
| 5 Year Change | 26.48% |
| Change since IPO | 50.62% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600216 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -6.1% | -0.6% | -2.8% |
| 1Y | 40.5% | -8.7% | 2.0% |
Return vs Industry: 600216 exceeded the CN Pharmaceuticals industry which returned -8.7% over the past year.
Return vs Market: 600216 exceeded the CN Market which returned 2% over the past year.
Price Volatility
| 600216 volatility | |
|---|---|
| 600216 Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 600216 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600216's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 6,227 | Chun Lei Lu | www.zmc.top |
Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceutical products in China. The company products include synthetic vitamin E, natural vitamin E, ß-carotene, cantharidin, vancomycin hydrochloride, and teicoplanin. It also offers fat-soluble vitamins, retinoids, quinolone antibiotics, anti-resistance antibiotics, and other products, as well as animal nutrition products.
Zhejiang Medicine Co., Ltd. Fundamentals Summary
| 600216 fundamental statistics | |
|---|---|
| Market cap | CN¥15.25b |
| Earnings (TTM) | CN¥977.95m |
| Revenue (TTM) | CN¥9.03b |
15.6x
P/E Ratio1.7x
P/S RatioIs 600216 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600216 income statement (TTM) | |
|---|---|
| Revenue | CN¥9.03b |
| Cost of Revenue | CN¥5.75b |
| Gross Profit | CN¥3.28b |
| Other Expenses | CN¥2.30b |
| Earnings | CN¥977.95m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.02 |
| Gross Margin | 36.30% |
| Net Profit Margin | 10.83% |
| Debt/Equity Ratio | 7.1% |
How did 600216 perform over the long term?
See historical performance and comparison